Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078390930> ?p ?o ?g. }
- W2078390930 endingPage "118" @default.
- W2078390930 startingPage "105" @default.
- W2078390930 abstract "Asymmetric dimethylarginine (ADMA) has evolved as an important regulator of nitric oxide (NO) synthesis in recent years. Elevated levels of ADMA have been reported in many conditions associated with a high cardiovascular risk. Moreover, ADMA is a biomarker for major cardiovascular events and mortality in cohorts with high, intermediate and low overall cardiovascular risk. Discrepant data have been reported on cardiovascular risk in people with and without diabetes mellitus, and the association of ADMA with diabetes mellitus per se has also remained controversial, possibly relating to type and stage of diabetes. Clinical and experimental data suggest that there is a multifaceted link between ADMA and insulin metabolism and action on one hand, and ADMA and glucose utilisation on the other. This interplay may be regulated by the enzyme involved in the metabolic degradation of ADMA, dimethylarginine dimethylaminohydrolase (DDAH). Recent data from prospective clinical studies suggest that whilst ADMA may be a marker for total mortality in patients without diabetes, elevated ADMA may exert beneficial effects in patients with diabetes. In this respect, ADMA could serve as a re-coupling agent overcoming endothelial nitric oxide synthase (eNOS) uncoupling in patients with diabetes. Anticipated advances in clinical and experimental investigation will help us to better understand this complex interrelationship between diabetes, eNOS, DDAH and ADMA." @default.
- W2078390930 created "2016-06-24" @default.
- W2078390930 creator A5001476401 @default.
- W2078390930 creator A5004656494 @default.
- W2078390930 creator A5038106053 @default.
- W2078390930 creator A5057764662 @default.
- W2078390930 creator A5058562840 @default.
- W2078390930 date "2010-03-17" @default.
- W2078390930 modified "2023-09-25" @default.
- W2078390930 title "Review article: Asymmetric dimethylarginine as a mediator of vascular dysfunction and a marker of cardiovascular disease and mortality: an intriguing interaction with diabetes mellitus" @default.
- W2078390930 cites W1965407804 @default.
- W2078390930 cites W1966790346 @default.
- W2078390930 cites W1974027949 @default.
- W2078390930 cites W1975365056 @default.
- W2078390930 cites W1981268963 @default.
- W2078390930 cites W1982811953 @default.
- W2078390930 cites W1983880210 @default.
- W2078390930 cites W1989115514 @default.
- W2078390930 cites W1990800912 @default.
- W2078390930 cites W1993387626 @default.
- W2078390930 cites W1995800794 @default.
- W2078390930 cites W1997307168 @default.
- W2078390930 cites W1998205437 @default.
- W2078390930 cites W2000700725 @default.
- W2078390930 cites W2000881220 @default.
- W2078390930 cites W2000940740 @default.
- W2078390930 cites W2001338200 @default.
- W2078390930 cites W2001778442 @default.
- W2078390930 cites W2002812827 @default.
- W2078390930 cites W2004688216 @default.
- W2078390930 cites W2009882244 @default.
- W2078390930 cites W2010079762 @default.
- W2078390930 cites W2010102296 @default.
- W2078390930 cites W2012214559 @default.
- W2078390930 cites W2012772537 @default.
- W2078390930 cites W2018466151 @default.
- W2078390930 cites W2025563165 @default.
- W2078390930 cites W2025623288 @default.
- W2078390930 cites W2029626898 @default.
- W2078390930 cites W2030620527 @default.
- W2078390930 cites W2031601643 @default.
- W2078390930 cites W2033525828 @default.
- W2078390930 cites W2033974115 @default.
- W2078390930 cites W2034393838 @default.
- W2078390930 cites W2035183978 @default.
- W2078390930 cites W2037734771 @default.
- W2078390930 cites W2038505321 @default.
- W2078390930 cites W2042782418 @default.
- W2078390930 cites W2042800607 @default.
- W2078390930 cites W2043426107 @default.
- W2078390930 cites W2044153197 @default.
- W2078390930 cites W2046761882 @default.
- W2078390930 cites W2049752509 @default.
- W2078390930 cites W2052806618 @default.
- W2078390930 cites W2054519962 @default.
- W2078390930 cites W2054949240 @default.
- W2078390930 cites W2056420431 @default.
- W2078390930 cites W2057232608 @default.
- W2078390930 cites W2058385357 @default.
- W2078390930 cites W2061976121 @default.
- W2078390930 cites W2063223047 @default.
- W2078390930 cites W2065111656 @default.
- W2078390930 cites W2065477280 @default.
- W2078390930 cites W2065501573 @default.
- W2078390930 cites W2067805552 @default.
- W2078390930 cites W2067862057 @default.
- W2078390930 cites W2068182431 @default.
- W2078390930 cites W2068381921 @default.
- W2078390930 cites W2071654814 @default.
- W2078390930 cites W2071958960 @default.
- W2078390930 cites W2072531665 @default.
- W2078390930 cites W2076680300 @default.
- W2078390930 cites W2082092019 @default.
- W2078390930 cites W2082661372 @default.
- W2078390930 cites W2083441169 @default.
- W2078390930 cites W2083691344 @default.
- W2078390930 cites W2088076675 @default.
- W2078390930 cites W2089736652 @default.
- W2078390930 cites W2092145002 @default.
- W2078390930 cites W2099957438 @default.
- W2078390930 cites W2102131871 @default.
- W2078390930 cites W2105082749 @default.
- W2078390930 cites W2106478344 @default.
- W2078390930 cites W2107588174 @default.
- W2078390930 cites W2107905182 @default.
- W2078390930 cites W2109944617 @default.
- W2078390930 cites W2110420172 @default.
- W2078390930 cites W2118316104 @default.
- W2078390930 cites W2119177204 @default.
- W2078390930 cites W2122545929 @default.
- W2078390930 cites W2126777636 @default.
- W2078390930 cites W2129050578 @default.
- W2078390930 cites W2129315200 @default.
- W2078390930 cites W2129367506 @default.
- W2078390930 cites W2130585857 @default.
- W2078390930 cites W2133371348 @default.
- W2078390930 cites W2135369804 @default.
- W2078390930 cites W2139203772 @default.